Online information on medical cannabis is not always aligned with scientific evidence and may raise unrealistic expectations.

Arthur Cassa Macedo, André Oliveira Vilela de Faria, Isabella Bizzi, Fabrício A Moreira, Alessandro Colasanti, Pietro Ghezzi
{"title":"Online information on medical cannabis is not always aligned with scientific evidence and may raise unrealistic expectations.","authors":"Arthur Cassa Macedo,&nbsp;André Oliveira Vilela de Faria,&nbsp;Isabella Bizzi,&nbsp;Fabrício A Moreira,&nbsp;Alessandro Colasanti,&nbsp;Pietro Ghezzi","doi":"10.1186/s42238-022-00145-w","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>There is a growing literature on the potential medical uses of Cannabis sativa and cannabinoid compounds. Although these have only been approved by regulatory agencies for a few indications, there is a hype about their possible benefits in a variety of conditions and a large market in the wellness industry. As in many cases patients search for information on cannabis products online, we have analyzed the information on medical cannabis available on the Internet. Therefore, this study aims at assessing the quality of the information available online on medical cannabis.</p><p><strong>Methods: </strong>We searched \"medical cannabis\" on June 2019 using google.com and downloaded the first 243 websites. After excluding dead links or websites with no information about cannabis, 176 websites were included. They were then classified for their typology (e.g., commercial, government, news outlets). As an indicator of trustworthiness, we used the Journal of American Medical Association (JAMA) score, which assesses the indication of date, author, ownership of the website, and the presence of references. We also considered if a website is certified by Health-On-the-Net (HON), an independent organization, by displaying a HONCode symbol. Subsequently, we performed a content analysis to assess both the medical cannabis indications mentioned by webpages and the completeness of the information provided (whether they mentioned potential side effects and legal/regulatory issues or not).</p><p><strong>Results: </strong>Analyzing 176 webpages returned by a search engine, we found that 52% of them were news websites. Pain, epilepsy, and multiple sclerosis were the most frequently mentioned therapeutic areas (cited in 92, 84 and 80 webpages, respectively), which did not always match those for which there is regulatory approval. Information was also incomplete, with only 22% of the webpages mentioning potential side effects. Health portal websites provided the most complete information, with all of them (n = 7) reporting side effects. On average, 80% of webpages had a neutral stance on the potential benefits of medical cannabis, with commercial websites having more frequently a positive stance (67%).</p><p><strong>Conclusions: </strong>We conclude that the information that can be found online is not always aligned in terms of the therapeutic areas for which science-based evidence is often still weak.</p>","PeriodicalId":15172,"journal":{"name":"Journal of Cannabis Research","volume":" ","pages":"37"},"PeriodicalIF":0.0000,"publicationDate":"2022-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277882/pdf/","citationCount":"6","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cannabis Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s42238-022-00145-w","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 6

Abstract

Background: There is a growing literature on the potential medical uses of Cannabis sativa and cannabinoid compounds. Although these have only been approved by regulatory agencies for a few indications, there is a hype about their possible benefits in a variety of conditions and a large market in the wellness industry. As in many cases patients search for information on cannabis products online, we have analyzed the information on medical cannabis available on the Internet. Therefore, this study aims at assessing the quality of the information available online on medical cannabis.

Methods: We searched "medical cannabis" on June 2019 using google.com and downloaded the first 243 websites. After excluding dead links or websites with no information about cannabis, 176 websites were included. They were then classified for their typology (e.g., commercial, government, news outlets). As an indicator of trustworthiness, we used the Journal of American Medical Association (JAMA) score, which assesses the indication of date, author, ownership of the website, and the presence of references. We also considered if a website is certified by Health-On-the-Net (HON), an independent organization, by displaying a HONCode symbol. Subsequently, we performed a content analysis to assess both the medical cannabis indications mentioned by webpages and the completeness of the information provided (whether they mentioned potential side effects and legal/regulatory issues or not).

Results: Analyzing 176 webpages returned by a search engine, we found that 52% of them were news websites. Pain, epilepsy, and multiple sclerosis were the most frequently mentioned therapeutic areas (cited in 92, 84 and 80 webpages, respectively), which did not always match those for which there is regulatory approval. Information was also incomplete, with only 22% of the webpages mentioning potential side effects. Health portal websites provided the most complete information, with all of them (n = 7) reporting side effects. On average, 80% of webpages had a neutral stance on the potential benefits of medical cannabis, with commercial websites having more frequently a positive stance (67%).

Conclusions: We conclude that the information that can be found online is not always aligned in terms of the therapeutic areas for which science-based evidence is often still weak.

Abstract Image

Abstract Image

Abstract Image

关于医用大麻的在线信息并不总是与科学证据一致,并可能引起不切实际的期望。
背景:关于大麻和大麻素化合物的潜在医学用途的文献越来越多。尽管这些药物仅被监管机构批准用于少数适应症,但它们在各种情况下可能带来的好处以及健康行业的巨大市场都被大肆宣传。由于在许多情况下,患者在网上搜索有关大麻产品的信息,我们分析了互联网上可获得的关于医用大麻的信息。因此,本研究旨在评估网上关于医用大麻信息的质量。方法:于2019年6月在谷歌网站上搜索“医用大麻”,下载前243个网站。在排除了死链接或没有大麻信息的网站后,共有176个网站被纳入其中。然后根据它们的类型(例如,商业、政府、新闻媒体)对它们进行分类。作为可信度的指标,我们使用了美国医学协会杂志(JAMA)评分,该评分评估了日期、作者、网站所有权和参考文献的存在。我们还考虑了网站是否通过显示HONCode符号获得了独立组织health - on - on - net (HON)的认证。随后,我们进行了内容分析,以评估网页提到的医用大麻适应症和所提供信息的完整性(是否提到潜在的副作用和法律/监管问题)。结果:通过分析某搜索引擎返回的176个网页,我们发现其中52%是新闻网站。疼痛、癫痫和多发性硬化症是最常被提及的治疗领域(分别在92、84和80个网页中被引用),这些领域并不总是与监管部门批准的领域相匹配。信息也不完整,只有22%的网页提到了潜在的副作用。健康门户网站提供的信息最完整,所有网站(n = 7)都报告了副作用。平均而言,80%的网页对医用大麻的潜在好处持中立态度,商业网站的积极态度更为频繁(67%)。结论:我们得出的结论是,在基于科学证据的治疗领域,可以在网上找到的信息并不总是一致的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信